Supplementation with Omega-3 fatty acids in the supportive treatment of depression – systematic review
DOI:
https://doi.org/10.12775/JEHS.2023.46.01.023Keywords
omega-3, depression, supplementation, brain, mood, immunity, neurotransmissionAbstract
Omega-3 is a polyunsaturated fatty acid (PUFA) with a double bond present at the ω-3 carbon atom. Recently, many neurobiologists and psychiatrists have been studying the involvement of inflammatory factors and mechanisms in the pathogenesis of depression, including factors like an improper diet with an excess of omega-6, gut dysbiosis, obesity, and autoimmune diseases. The present study focuses on the impact of unsaturated fatty acids on mood improvement and cognitive processes in elderly patients with major depressive disorder (MDD) resistant to standard treatment. This form of depression is often associated with autoimmune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus, and inflammatory bowel diseases. The influence of omega-3 supplementation on depression prevention and its effects on childhood depression were also examined. It should be noted that some publications do not confirm the antidepressant effects of omega-3. However, this article provides evidence of the supportive role of omega-3 in depression treatment, based on neuroendocrine, metabolic, and immunological reactions.
Objective: Literature review on the impact of omega-3 on depression treatment, considering its forms, inflammatory mechanisms, neuroendocrine factors, diet, lifestyle, and age.
Materials and Methods: Literature review based on available sources from PubMed and Google Scholar.
Conclusions: Omega-3 is a polyunsaturated fatty acid that positively affects the functioning of the body. Many research studies confirm its antidepressant and anti-inflammatory effects, making it a potential adjunctive treatment for depression, especially in elderly patients with major treatment-resistant depression (MDD) coexisting with other chronic diseases. The results of studies on the relationship between omega-3 and antidepressant action also depend on various environmental factors and lifestyle choices.
References
Maggie B. Covington. 2004. Omega-3 Fatty Acids. Am Fam Physician. 70(1):133-140 https://www.aafp.org/pubs/afp/issues/2004/0701/p133.html?
J. A. Tur, M. M. Bibiloni, A. Sureda,A. Pons. 2012. Dietary sources of omega 3 fatty acids: public health risks and benefits. Published online by Cambridge University Press. https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/dietary-sources-of-omega-3-fatty-acids-public-health-risks-and-benefits/0C287B125293EF075DFF6169154201A6
Tomasz Wcisło, Waldemar Rogowski. 2006. The role of polyunsaturated fatty acids in human health. Cardiovascular Forum 2006, 11, 3, xx-xx. https://spezialist.marinex.com.pl/pliki_artykuly/ekspertyzy_naukowe_11.pdf
Jarosław Sobiś, Łukasz Kunert, Mariusz Sołtysik, Magdalena Piegza, Robert Pudlo, Piotr W. Gorczyca. 2015. Omega-3 polyunsaturated fatty acids in the prevention of affective disorders. Selected epidemiological data concering the use of omega-3 in the prevention of affective disorders. Psychiatry 2015. 12, 3: 147–152 https://journals.viamedica.pl/psychiatria/article/view/43645/31587
Kamila Krawczyk, Janusz Rybakowski. 2007. Zastosowanie kwasów tłuszczowych omega-3 w leczeniu depresji. Farmakoterapia w Psychiatrii i Neurologii, 2, 101–107
Grosso, G., Galvano, F., Marventano, S., Malaguarnera, M., Bucolo, C., Drago, F., & Caraci, F. (2014). Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxidative medicine and cellular longevity, 2014, 313570.
Su K. P. (2009). Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'?. Neuro-Signals, 17(2), 144–152.
Simopoulos A. P. (2002). Omega-3 fatty acids in inflammation and autoimmune diseases. Journal of the American College of Nutrition, 21(6), 495–505.
Suneson, K., Lindahl, J., Chamli Hårsmar, S., Söderberg, G., & Lindqvist, D. (2021). Inflammatory Depression-Mechanisms and Non-Pharmacological Interventions. International journal of molecular sciences, 22(4), 1640
Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut microbes and the brain: Paradigm shift in neuroscience. J Neurosci. 2014;34:15490–15496.
Cryan JF, Dinan TG. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience. 2012;13:701–712
Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinol Lett. 2008;29:117–124.
Keri S, Szabo C, Kelemen O. Expression of toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder. Brain Behavior and Immunity. 2014;40:235–243.
Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Staerkel P, Windey K, Tremaroli V, Backhed F, Verbeke K, de Timary P, Delzenne NM. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A. 2014;111:E4485–E4493.
Dinan TG, Stanton C, Cryan JF. Psychobiotics: A novel class of psychotropic. Biol Psychiatry. 2013;74:720–726.
Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, Houdeau E, Fioramonti J, Bueno L, Theodorou V. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology. 2012;37:1885–1895
Rahe C, Unrath M, Berger K. Dietary patterns and the risk of depression in adults: A systematic review of observational studies. Eur J Nutr. 2014;53:997–1013KK10.
Lai JS, Hiles S, Bisquera A, Hure AJ, McEvoy M, Attia J. A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. Am J Clin Nutr. 2014;99:181–197.
Sanchez-Villegas A, Delgado-Rodriguez M, Alonso A, Schlatter J, Lahortiga F, Majem LS, Martinez-Gonzalez MA. Association of the Mediterranean dietary pattern with the incidence of depression: The Seguimiento Universidad de Navarra/University of Navarra Follow-up (SUN) cohort. Arch Gen Psychiatry. 2009;66:1090–1098.
Rienks J, Dobson AJ, Mishra GD. Mediterranean dietary pattern and prevalence and incidence of depressive symptoms in mid-aged women: Results from a large community-based prospective study. Eur J Clin Nutr. 2013;67:75–82.
Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D’Armiento M, D’Andrea F, Giugliano D. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA. 2004;292:1440–1446.
Milaneschi Y, Bandinelli S, Penninx BW, Vogelzangs N, Corsi AM, Lauretani F, Kisialiou A, Vazzana R, Terracciano A, Guralnik JM, Ferrucci L. Depressive symptoms and inflammation increase in a prospective study of older adults: A protective effect of a healthy (Mediterranean-style) diet. Mol Psychiatry. 2011;16:589–590.
Lucas M, Chocano-Bedoya P, Shulze MB, Mirzaei F, O’Reilly EJ, Okereke OI, Hu FB, Willett WC, Ascherio A. Inflammatory dietary pattern and risk of depression among women. Brain Behav Immun. 2014;36:46–53.
Fontana L Neuroendocrine factors in the regulation of inflammation: Excessive adiposity and calorie restriction. Exp Gerontol. 2009;44:41–45
Aksungar FB, Topkaya AE, Akyildiz M. Interleukin-6, C-reactive protein and biochemical parameters during prolonged intermittent fasting. Ann Nutr Metab. 2007;51:88–95.
Fond G, Macgregor A, Leboyer M, Michalsen A. Fasting in mood disorders: Neurobiology and effectiveness. A review of the literature. Psychiatry Res. 2013;209:253–258.
McIntyre RS, Konarski JZ, Wilkins K, Soczynska JK, Kennedy SH. Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well-being. Can J Psychiatry, 2006;51:274—80.
Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med 2009;36:341—50.
Carey M, Small H, Yoong SL, Boyes A, Bisquera A, Sanson Fisher R. Prevalence of comorbid depression and obesity in general practice: a cross-sectional survey. Br J Gen Pract 2014;64:e122—7.
Faith MS, Butryn M, Wadden TA, Fabricatore A, Nguyen AM, Heymsfield SB. Evidence for prospective associations among depression and obesity in population-based studies. Obes Rev 2011;12:e438—53.
Lin KP, Liang TL, Liao IC, Tsay SL. Associations among depression, obesity, and metabolic syndrome in young adult females. Biol Res Nurs 2013;16:327—34.
Bornstein SR, Schuppenies A, Wong ML, Licinio J. Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry 2006;11:892—902.
Hryhorczuk C, Sharma S, Fulton SE. Metabolic disturbances connecting obesity and depression. Front Neurosci 2013;7:177.
Olszanecka-Glinianowicz, Magdalena. "Depresja-przyczyna czy skutek otyłości?." Endokrynologia, Otyłość i Zaburzenia Przemiany Materii 4.2 (2008): 78-85.
Redrobe J.P., Dumont Y., Quirion R.: Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sci. 2002; 71: 2921–2937.
Strombom U., Krotkiewski M., Blennow K. i wsp.: The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution. Int. J. Obes. 1996; 20: 361–368.
Lambert G.W., Vaz M., Cox H.S. i wsp.: Human obesity is associated with chronic elevation in brain 5-hydroxytryptamine turnover. Clin. Sci. 1999; 96: 191––197.
Wang G.J., Volkow N.D., Logan J. i wsp.: Brain dopamine and obesity. Lancet 2001; 357: 354–357.
Zahorska-Markiewicz B., Obuchowicz E., Waluga M. i wsp.: Neuropeptide Y in obese women during treatment with adrenergic modulation drugs. Med. Sci. Monit. 2001; 7: 403–408
MacQueen G., Chokka P. Special iSsues in the management of depression in women. Can. J. Psychiatry 2004; 49: 27–40.
Muldoon M.F., Mackey R.H., Williams K.V. i wsp.: Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity. J. Clin. Endocrinol. Metab. 2004; 89: 266–271.
Eaton K., Sallee F.R., Sah R.: Relevance of neuropeptide Y (NPY) in psychiatry. Curr. Top. Med. Chem. 2007; 7: 1645–1659.
Veith R.C., Lewis N., Linares O.A. i wsp.: Sympathetic nervous system activity in major depression. Basal and desipramine — induced alterations in plasma norepinephrine kinetics. Arch. Gen. Psychiatry 1994; 51: 411–422.
Davy K.P.: The global epidemic obesity: are we becoming more sympathetic? Curr. Hypertens. Rep. 2004; 6:241–246.
Hilton S.M.: The defense-arousal system and its relevance for circulation and respiratory control. J. Exper. Biol. 1982; 100: 159–174.
Hjemdahl P., Freyschuss U., Juhlin Dannfelt A. i wsp.: Differentiated sym pathetic activation during mental stress evoked by Stroop test. Acta. Physiol. Scand. 1984; 527: 25–29.
Sung B.H., Wilson M.F., Izzo J.L., Ramirez L., DandonaP.: Moderately obese insulin-resistant women exhibit abnormal vascular reactivity to stress Hypertension 1997; 30: 848–853.
Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002 Oct;56(8):365-79.
Liao, Y., Xie, B., Zhang, H., He, Q., Guo, L., Subramanieapillai, M., Fan, B., Lu, C., & McIntyre, R. S. (2019). Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational psychiatry, 9(1), 190.
Kiecolt-Glaser JK, Derry HM, Fagundes CP. Inflammation: depression fans the flames and feasts on the heat. Am J Psychiatry. 2015 Nov 1;172(11):1075-91.
Opie RS, Itsiopoulos C, Parletta N, Sanchez-Villegas A, Akbaraly TN, Ruusunen A, Jacka FN. Dietary recommendations for the prevention of depression. Nutr Neurosci. 2017;20(3):161-171.
Kris-Etherton PM, Petersen KS, Hibbeln JR, Hurley D, Kolick V, Peoples S, Rodriguez N, Woodward-Lopez G. Nutrition and behavioral health disorders: depression and anxiety. Nutr Rev. 2021;79(3):247-260.
Sánchez-Villegas, A., Álvarez-Pérez, J., Toledo, E., Salas-Salvadó, J., Ortega-Azorín, C., Zomeño, M. D., Vioque, J., Martínez, J. A., Romaguera, D., Pérez-López, J., López-Miranda, J., Estruch, R., Bueno-Cavanillas, A., Arós, F., Tur, J. A., Tinahones, F. J., Lecea, O., Martín, V., Ortega-Calvo, M., Vázquez, C., … Serra-Majem, L. (2018). Seafood Consumption, Omega-3 Fatty Acids Intake, and Life-Time Prevalence of Depression in the PREDIMED-Plus Trial. Nutrients, 10(12), 2000.
Chae, M., & Park, K. (2021). Association between dietary omega-3 fatty acid intake and depression in postmenopausal women. Nutrition research and practice, 15(4), 468–478.
Okereke, O. I., Vyas, C. M., Mischoulon, D., Chang, G., Cook, N. R., Weinberg, A., Bubes, V., Copeland, T., Friedenberg, G., Lee, I. M., Buring, J. E., Reynolds, C. F., 3rd, & Manson, J. E. (2021). Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. JAMA, 326(23), 2385–2394.
Red. Janas-Kozik Małgorzata; Wolańczyk Tomasz. 2021. Psychiatria dzieci i młodzieży. Tom 1. PWL Wydawnictwo Lekarskie, 480-493 s. ISBN 978-83-200-6510-7, doi:
https://ezop.edu.pl/wp-content/uploads/2021/12/EZOPII_Rozpowszechnienie.pdf
McNamara RK, Almeida DM. 2019. Niedobór wielonienasyconych kwasów tłuszczowych omega-3 i postępująca neuropatologia w zaburzeniach psychicznych: przegląd dowodów translacyjnych i mechanizmów kandydujących. Harvard Review of Psychiatry; 27 ( 2 ):94-107.
Rice SM, Hickie IB, Yung AR, et al. 2016. Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial. Early Interv Psychiatry.10(4):290-299. doi:10.1111/eip.12166
Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN. Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2012;
Newberry SJ, Chung M, Booth M, Maglione MA, Tang AM, et al. 2016. Omega-3 fatty acids and maternal and child health: an updated systematic review. Evid. Rep./Technol. Assess. Number 224 Rep. 16(17)-E003-EF, Agency Healthc. Res. Qual., Rockville, MD
Farquharson J, Jamieson EC, Abbasi KA, Patrick WJ, Logan RW, Cockburn F. 1995. Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Arch. Dis. Child. 72: 198–203
Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. 2006. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 163(6):1098-1100.
Nevins JEH, Donovan SM, Snetselaar L, et al. 2021. Omega-3 Fatty Acid Dietary Supplements Consumed During Pregnancy and Lactation and Child Neurodevelopment: A Systematic Review. J Nutr.151(11):3483-3494.
Campisi SC, Zasowski C, Bradley-Ridout G, Szatmari P, Korczak DJ. 2022. 1.25 Omega-3 Fatty Acid Supplementation for Depression in Children and Adolescents: A Systematic Review and Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 61(10):S149.
https://www.who.int/news-room/fact-sheets/detail/depression (dostęp 24.07.2023)
Appleton KM, Voyias PD, Sallis HM, Dawson S, Ness AR, Churchill R, Perry R. Omega‐3 fatty acids for depression in adults. Cochrane Database of Systematic Reviews 2021, Issue 11. Art. No.: CD004692. DOI: 10.1002/14651858.CD004692.pub5. Accessed 20 July 2023.
Mocking, R. J., Harmsen, I., Assies, J., Koeter, M. W., Ruhé, H. G., & Schene, A. H. (2016). Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Translational psychiatry, 6(3), e756.
Wani, A. L., Bhat, S. A., & Ara, A. (2015). Omega-3 fatty acids and the treatment of depression: a review of scientific evidence. Integrative medicine research, 4(3), 132–141.
Lin, P.-Y., Mischoulon, D., Freeman, M. P., Matsuoka, Y., Hibbeln, J., Belmaker, R. H., & Su, K.-P. (2012). Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation and severity of depression. Molecular Psychiatry, 17(12), 1161–1163
Christos F. Kelaiditis, E.Leigh Gibson, Simon C. Dyall, Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials, Prostaglandins, Leukotrienes and Essential Fatty Acids, Volume 192,2023,102572,ISSN 0952-3278
S.C. Dyall, H.K. Mandhair, R.E.A. Fincham, D.M. Kerr, M. Roche, F. Molina-Holgado, Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways, Neuropharmacology, Volume 107, 2016, 387-395, ISSN 0028-3908,
Parker, G., Gibson, N. A., Brotchie, H., Heruc, G., Rees, A. M., & Hadzi-Pavlovic, D. (2006). Omega-3 fatty acids and mood disorders. The American journal of psychiatry, 163(6), 969–978.
Safa, M., Fallah Tafti, S., Ghassem Boroujerdi, F., & Talischi, F. (2013). Clinical trial in the treatment of 80 Iranian patients with major depression disorder by the combination of omega 3 fatty acid and a selective serotonin reuptake inhibitor. Therapeutic advances in psychopharmacology, 3(4), 186–190.
Beydoun, M. A., Fanelli Kuczmarski, M. T., Beydoun, H. A., Hibbeln, J. R., Evans, M. K., & Zonderman, A. B. (2013). ω-3 fatty acid intakes are inversely related to elevated depressive symptoms among United States women. The Journal of nutrition, 143(11), 1743–1752.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Karolina Chmielarz, Magdalena Zapała, Adrian Hunek, Karolina Kaziród, Joanna Wiśniewska-Skomra, Kinga Tylutka, Anna Hapon
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 1625
Number of citations: 0
